The Compounded Semaglutide Problem In South Africa

This is one of the most important articles on this site. Not because the medication is dangerous (Wegovy is well studied and reasonably safe). Because the SA market is now flooded with unregulated copies of semaglutide, and many people are using them without realising what they are buying.

The numbers are striking. According to industry estimates referenced by Novo Nordisk South Africa, roughly one in two South Africans on weight loss treatment is using an unauthorised compounded version of semaglutide rather than the regulated branded product. This is happening even after Wegovy launched locally in August 2025 and even after price reductions in early 2026.

What Is Compounded Semaglutide

'Compounded' in pharmacy normally refers to a pharmacist mixing a customised version of a medication for a specific patient with a specific clinical need, where no commercial product fits. It is a legitimate practice for things like custom doses, specific allergy considerations, or specialised paediatric preparations.

What is happening with semaglutide is different. Some operators, both online and through some weight loss clinics, are producing or importing bulk semaglutide and dispensing it outside the regulated pharmacy chain. Often labelled as 'compounded semaglutide', 'research peptides', or simply 'semaglutide' at a lower price.

This is not the same thing as commercial Wegovy or Ozempic. The active ingredient may or may not be present at the labelled dose. The purity is unverified. The manufacturing is unregulated.

Why This Matters

Several specific risks.

Dose inaccuracy

Without commercial pharmaceutical manufacturing controls, the amount of semaglutide in each vial or pen can vary significantly. Some doses are higher than labelled (increased side effect risk). Some are lower (no clinical effect). Some are essentially nothing.

Contamination

Bulk powder semaglutide sourced from unregulated suppliers (often China and India) sometimes contains impurities, contaminants, or other unintended substances. Testing by various national regulators has found everything from bacterial contamination to substituted active ingredients.

Falsification

Some products labelled as semaglutide contain a different active ingredient entirely, or no active ingredient at all. Insulin substitution has been documented, which is genuinely dangerous because insulin can cause life threatening hypoglycaemia in people without diabetes.

No safety oversight

Regulated semaglutide goes through manufacturing quality control, stability testing, batch tracking, and post-marketing safety surveillance. None of this applies to compounded or unregulated versions. If something goes wrong with a batch, there is no recall mechanism.

No medical oversight

Most compounded semaglutide sellers operate without proper medical assessment, prescription, or follow up. The customer fills out a brief form, the product ships, and that is it. The eligibility checks, contraindication screening, and dose titration that a proper consultation provides are missing.

What SAHPRA Has Said

SAHPRA has issued formal warnings about substandard and falsified semaglutide and GLP-1 products in South Africa. The regulator has moved to classify such products as 'undesirable' under medicines law, which expands enforcement powers.

Novo Nordisk has separately pursued legal action against a local compounder. Court cases are still working through the system.

How To Spot The Real Thing

Genuine Wegovy in South Africa:

• Is dispensed by a SAPC registered pharmacy
• Comes in a clearly branded Novo Nordisk box
• Contains a pre-filled pen with the dose marking visible
• Has a SAHPRA registration number on the packaging
• Was issued against a valid prescription from a registered SA doctor
• Has a batch number and expiry date
• Costs in the range described on our cost page

What to be suspicious of:

• Vials of liquid sold for self-drawing into syringes
• Pens with generic labels or no branding
• Bulk powder for reconstitution
• Products purchased online without a prescription
• Products from non-pharmacy sellers (weight loss clinics that supply directly, online sellers, social media operators)
• Significantly lower prices than the regulated range
• 'Research only' or 'not for human use' labelling that is then prescribed as treatment

The Cost Tension

The reason people use compounded products is straightforward: they are cheaper. Often substantially so. R600 or R800 a month versus R1,800 to R3,700 a month for the regulated product is a real difference, particularly in the SA economic context where medical aid does not always cover weight management.

This is a genuine tension. Health authorities want people to use only regulated products. Many people cannot easily afford regulated prices. The compounded market exists in the gap.

What is changing this:

• Wegovy price reductions in early 2026 narrowed the cost gap
• Eventual patent expiry will produce genuine generic semaglutide (regulated, much cheaper)
• Slow movement on medical aid coverage
• Continued enforcement against the worst compounding operations

Practical Advice

If you are considering using compounded semaglutide, understand what you are accepting:

• The product may or may not contain what is claimed
• The dose may not be accurate
• There is no safety net if something goes wrong
• The medical assessment is usually minimal
• Insurance and medical aid will not cover the treatment

If you are currently using compounded semaglutide, consider switching to the regulated product. A proper consultation with a SA doctor, prescription, and pharmacy collection is straightforward. The cost is real but the safety is genuinely better.

If you cannot afford regulated Wegovy, talk to a doctor about the alternatives. Older medications (liraglutide as Saxenda, orlistat) are cheaper and still regulated. Structured non-medication weight management is also a legitimate path. None of these match Wegovy's average results, but all are safer than unregulated copies.

The Bottom Line

The compounded semaglutide market in SA exists because of a real affordability problem. The solution is not to use unregulated products. The solution is regulated treatment at the dose and indication that fits your situation, even if that means a different medication or no medication. Your safety matters more than maximum weight reduction.